CClinicalTrials.gg
CompletedNCT07186543Updated Jun 23, 2026

Co-Designing a Virtual Reality Intervention to Enhance Skill Development

An interventional study of Cognitive Behavioral Therapy (CBT) Worksheets and Practice Experiences for School Reintegration (PrESR) in Suicide, sponsored by University of North Carolina, Chapel Hill. Completed at 1 site in United States. Open to participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-06-23.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
13 Years to 18 Years
Sex
All
01

Study summary

This study is refining and pilot testing a novel Virtual Reality (VR) supplement for inpatient treatment: the Practice Experiences for School Reintegration (PrESR) program. The PrESR provides immersive school and social experiences for inpatient adolescents (with suicidal-related admissions) to practice skills in real-world settings with the guidance of a trained clinician within the confines of a hospital. The initial intervention was based on feedback from adolescent hospitalized for suicide-related crises, and school and hospital professionals, but did not provide tailored experiences to address the individual needs of ethnic-racial, gender, and sexual minoritized adolescents. Therefore, the VR environment of PrESR was adapted based on input from adolescents with previous suicide-related crises identifying as ethnic, racial, sex, or gender minoritized. This pilot randomized controlled trial (RCT) aims to explore the feasibility, acceptability, and facilitators/barriers to implementation of the adapted version of PrESR for improving outcomes in hospitalized adolescents. This study is not powered to test hypotheses; however, in addition to assessing feasibility, acceptability, and barriers/facilitators, this pilot trial will assess candidate intermediary and outcome measures.

Read the detailed description

This study recruits a prospective sample of youth hospitalized for suicide-related crises. Target sample size is approximately N = 26 enrolled adolescents, with the intention of recruiting at least 16 participants who identify as ethnic, racial, sex, or gender minoritized. The pilot RCT includes two conditions: an enhanced treatment as usual condition and an experimental condition. All participants will receive standard treatment, as well as researcher provided worksheets addressing introduction to cognitive behavioral therapy, cognitive restructuring, problem-solving, and affect regulation. Participants randomized to the experimental condition will also receive one or more sessions with PrESR. Outcomes will be assessed during hospitalization and again 3-weeks following hospital discharge.

02

Conditions studied

  • Suicide

Browse trials for

03

In context

Suicide

701 studies on the registry are indexed under Suicide; 183 are open to participants now.

This study's enrollment of 26 is below the median of 104 across 560 interventional studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,340 studies on the registry; 133 are open to participants now.

Of its 155 completed or terminated interventional studies of FDA-regulated products, 136 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Current hospitalization for suicidal thoughts and behaviors
  • Ages 13-18
  • Clinician approval
  • Ability to speak, read, and understand English sufficiently to complete study procedures
  • Consent of a parent/legal guardian (in English or Spanish; for minor participants)
  • Adolescent assent or consent (in English)

Exclusion criteria

Exclusion Criteria:

  • Evidence of active psychosis
  • Evidence of intellectual disability
  • Risk for cybersickness (greater or equal to 50th percentile as measured on the Motion Sickness Susceptibility Questionnaire).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
26 participants (actual)

Study arms

  • Active comparator
    Enhanced Control

    Cognitive Behavioral Therapy (CBT) Worksheets

    Behavioral: Cognitive Behavioral Therapy (CBT) Worksheets

  • Experimental
    PrESR Intervention

    Cognitive Behavioral Therapy (CBT) Worksheets; Virtual Reality (VR) Enhanced CBT Skill/Practice; Safety Planning

    Behavioral: Cognitive Behavioral Therapy (CBT) Worksheets · Behavioral: Practice Experiences for School Reintegration (PrESR)

Interventions

  • BehavioralCognitive Behavioral Therapy (CBT) Worksheets

    The researchers will provide instructions for participants to complete a packet of worksheets teaching introduction to cognitive behavioral therapy (CBT), affect regulation, cognitive restructuring, and problem solving.

  • BehavioralPractice Experiences for School Reintegration (PrESR)

    Participants will receive an overview of cognitive behavioral therapy skills in virtual reality (VR) and then have the opportunity to practice using skills in a brief immersive experience designed to mimic difficult school and social experiences. Session begin with goal setting and conclude with a debrief summary following the VR experience. Prior to discharge and following the conclusion of the VR sessions, participants will be invited to collaborate on a safety planning intervention informed by their experiences in VR that addresses school and social experiences.

06

What researchers measure

Primary outcomes

  1. Proportion of Patients in the Target Population Who Agree to Participate

    Recruitment rate determined based on the proportion of adolescents providing assent and parents or legal guardians providing permission relative to the number of parents or legal guardians approached.

    Time frame: Baseline

  2. Proportion of Patients in the Target Population Excluded Due to Motion Sickness Screening

    Rate of recruitment related to motion sickness determined based on the proportion of assented adolescents whose scores were \>/= than 50th percentile on motion sickness questionnaire relative to the number of assented adolescents.

    Time frame: Baseline

  3. Proportion of Participants Who Complete All Study Procedures

    Proportion of participants who complete all study procedures determined based on the proportion of adolescents completing study procedures at Baseline and 3-week follow-up relative to the total number of adolescents participating in that condition.

    Time frame: up to 3-weeks following hospital discharge

  4. Average Number of Hours to Complete Assessments at Each Time Point

    Time to complete assessments, assessments are expected to last less than 4 hours.

    Time frame: up to 3-weeks following hospital discharge

  5. Average Number of Minutes to Complete Each Intervention Session

    Time to complete intervention sessions, each session is expected to last less than 60 minutes. Average calculated by summing all sessions in each condition and dividing by total number of sessions.

    Time frame: Baseline

  6. Percentage of Adolescent Participants in Which Intervention Delivered With Greater Than or Equal to 80% Fidelity

    Percentage of participants in which adherence to delivery of key components of intervention (i.e., skill lessons or practice sessions) across sessions in each condition was 80% or greater. Adherence calculated based on the number of key components completed relative to the total number of key components expected to be completed for each participant.

    Time frame: Baseline

  7. Percentage of Adolescent Participants With Average Acceptability Scores Less Than or Equal to 2

    Percent of adolescents with average acceptability score less than or equal to 2 (or "agree") on a structured feedback form developed by the researchers. The structured feedback form includes an average of four items related to acceptability on a five-point scale from 1 (strongly agree) to 5 (strongly disagree), with lower scores reflecting higher acceptability.

    Time frame: Baseline

  8. Adolescents' Perceptions of Acceptability

    Qualitative feedback provided by adolescents receiving the intervention about acceptability of the intervention, with the two most common points of feedback collected from a structured interview reported.

    Time frame: Baseline

07

Study locations

1 site
  • UNC Adolescent Psychiatry Inpatient Unit
    Chapel Hill, North Carolina 27599, United States
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07186543
Lead sponsor
University of North Carolina, Chapel Hill
Collaborators
MQ Mental Health Research
Responsible party
Sponsor
First posted
Sep 22, 2025
Start date
Oct 13, 2025
Primary completion
Jun 10, 2026
Completion
Jun 10, 2026
Last update
Jun 23, 2026

Study contacts

Marisa Marraccini, PhD
principal investigator · University of North Carolina, Chapel Hill

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion